Skip to main content

Envisioning is an emerging technology research institute and advisory.

LinkedInInstagramGitHub

2011 — 2026

research
  • Reports
  • Newsletter
  • Methodology
  • Origins
  • Vocab
services
  • Research Sessions
  • Signals Workspace
  • Bespoke Projects
  • Use Cases
  • Signal Scanfree
  • Readinessfree
impact
  • ANBIMAFuture of Brazilian Capital Markets
  • IEEECharting the Energy Transition
  • Horizon 2045Future of Human and Planetary Security
  • WKOTechnology Scanning for Austria
audiences
  • Innovation
  • Strategy
  • Consultants
  • Foresight
  • Associations
  • Governments
resources
  • Pricing
  • Partners
  • How We Work
  • Data Visualization
  • Multi-Model Method
  • FAQ
  • Security & Privacy
about
  • Manifesto
  • Community
  • Events
  • Support
  • Contact
  • Login
ResearchServicesPricingPartnersAbout
ResearchServicesPricingPartnersAbout
  1. Home
  2. Research
  3. Helix
  4. Blood Plasma Exchange Networks

Blood Plasma Exchange Networks

Regional clinics offering therapeutic plasma exchange for aging biomarkers.
Back to HelixView interactive version

Therapeutic plasma exchange programs are networks of regional clinics that offer plasmapheresis (a procedure that removes, treats, and returns blood plasma) as a therapeutic intervention for aging, replacing aged plasma with albumin-enriched solutions based on research suggesting that young plasma contains factors that can rejuvenate aged tissues. Longevity clinics are rolling out plasmapheresis suites with standardized protocols, remote supervision capabilities, and bundled biomarker panels that track aging markers, making the therapy accessible beyond research centers and available to patients seeking anti-aging interventions. Companies and clinics are developing these services.

This innovation addresses research suggesting that factors in young blood can have rejuvenating effects, where plasma exchange could potentially transfer beneficial factors or remove harmful ones. By standardizing and scaling the procedure, these programs make it accessible to more people. However, the scientific basis and effectiveness remain areas of active research.

The technology is being explored for longevity applications, where plasma exchange could potentially have anti-aging effects. As research progresses, these programs could become more established. However, ensuring safety, demonstrating effectiveness, and managing costs remain challenges. The technology represents an interesting approach to anti-aging interventions, but requires continued research to establish efficacy and safety. Success could provide new options for healthy aging, but the scientific basis needs further validation and the approach must be carefully evaluated for safety and effectiveness.

TRL
6/9Demonstrated
Impact
4/5
Investment
4/5
Category
Applications

Related Organizations

Grifols logo
Grifols

Spain · Company

95%

Global healthcare company and producer of plasma-derived medicines.

Deployer
Alkahest logo
Alkahest

United States · Company

90%

Biotech company identifying proteins in plasma that change with age to develop targeted therapies.

Researcher
Lyfspn logo
Lyfspn

United States · Startup

90%

Organization founded by Dr. Dobri Kiprov focusing on therapeutic plasma exchange for longevity.

Deployer
UC Berkeley logo
UC Berkeley

United States · University

90%

Home to the Conboy Lab (Irina and Michael Conboy).

Researcher
Young Blood Institute logo
Young Blood Institute

United States · Nonprofit

85%

A non-profit corporation researching new uses for Therapeutic Plasma Exchange.

Researcher
Betterhumans logo
Betterhumans

United States · Nonprofit

80%

A non-profit organization conducting small-scale clinical trials on longevity interventions.

Researcher
Fountain Life logo
Fountain Life

United States · Company

75%

A preventative health platform providing advanced diagnostics and vetted therapeutics to detect and treat age-related diseases early.

Deployer
Next Health

United States · Company

70%

A health optimization center offering cryotherapy, IV therapy, and biomarker testing in a retail setting.

Deployer

Supporting Evidence

Evidence data is not available for this technology yet.

Same technology in other hubs

Epoch
Epoch
Therapeutic Plasma Exchange

Filtering blood plasma to remove aging factors and restore youthful circulation

Connections

Applications
Applications
Systemic Milieu Reset Protocols

Plasmapheresis and plasma-mimetic therapies to rebalance pro- and anti-aging factors.

TRL
4/9
Impact
4/5
Investment
4/5
Applications
Applications
Partial Reprogramming Therapies

Transient expression of Yamanaka factors targeting aging phenotypes.

TRL
4/9
Impact
5/5
Investment
5/5
Applications
Applications
Immune System Rejuvenation Therapies

Interventions targeting thymic involution and clonal hematopoiesis in aging.

TRL
4/9
Impact
5/5
Investment
3/5
Applications
Applications
Swiss Longevity Clinic Models

Integrated programs combining biomarker labs, imaging, and concierge care.

TRL
7/9
Impact
3/5
Investment
3/5
Applications
Applications
Precision Longevity Interventions

Personalized stacks of therapeutics and lifestyle modifications.

TRL
7/9
Impact
4/5
Investment
4/5
Software
Software
In-Silico Longevity Drug Repurposing Engines

AI platforms identifying geroprotective properties in existing non-longevity drugs.

TRL
8/9
Impact
4/5
Investment
3/5

Book a research session

Bring this signal into a focused decision sprint with analyst-led framing and synthesis.
Research Sessions